Form 4 for NRC NRC HEALTH
Accepted 2025-10-01 00:00:00 ET · period of report 2025-09-29 · accession 0001008886-25-000265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-01 | 2025-09-29 | NRC | HARRISON SHANE R | EVP, CFO | A - Grant | $0.00 | +172.0K | 172.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-29 | A | A | 172,000 | $0.00 | 172,000 | D | — | — | (F1) Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares vest in four equal installments on the following dates: (i) December 28, 2025, (ii) September 29, 2026, (iii) September 29, 2027, and (iv) September 29, 2028. |